ArticleBMC medicine2026

PROTAC-mediated PCSK9 degradation attenuates atherosclerosis and improves plaque composition via suppression of NF-κB/TNF-α pathway.

Xin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.